cyclosporine has been researched along with Chemical and Drug Induced Liver Injury in 110 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.91) | 18.7374 |
1990's | 23 (20.91) | 18.2507 |
2000's | 28 (25.45) | 29.6817 |
2010's | 44 (40.00) | 24.3611 |
2020's | 14 (12.73) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Norman, BH | 1 |
Callegaro, G; den Hollander, W; Furlong, L; Grosdidier, S; Guney, E; Kunnen, SJ; Mollon, J; Niemeijer, M; Piñero Gonzalez, J; Saez-Rodriguez, J; Stevens, JL; Sutherland, JJ; Trairatphisan, P; van de Water, B; Webster, YW | 1 |
El-Sayed, NM; Faheem, SA; Hazem, RM; Moustafa, YM; Saeed, NM | 1 |
Cao, Z; Huang, L; Liao, X; Liu, F; Liu, J; Lu, H; Wan, M; Wang, Y; Xiao, J; Xiong, G; Yang, D; Zhang, S | 1 |
Ahmed, YM; Elsayed, NM; Faheem, SA; Hazem, RM; Saeed, NM | 1 |
Matsukawa, T; Miyagishima, T; Nagai, J; Oshimi, K; Suto, K | 1 |
Bekpinar, S; Bingul, I; Olgac, V; Uysal, M | 1 |
Li, T; Luo, Z; Wei, Y; Wu, Q; Xiao, W; Yu, Y; Zhou, K | 1 |
Bajaj, P; Harada, K; Kohara, H; Matsui, T; Miyamoto, K; Miyawaki, A; Okai, Y; Shinozawa, T; Wagoner, M; Yamanaka, K | 1 |
Das, P; Kumar, VL; Vangaveti, S | 1 |
Enver Ozan, İ; Erdem Güzel, E; Gül, M; Kavak Balgetir, M; Kaya Tektemur, N; Ozan Kocamüftüoğlu, G; Özcan Yıldırım, S; Tektemur, A; Yalçın, T | 1 |
Abdelmageed, ME; Nader, MA; Serrya, MS | 1 |
Adebayo, A; Adefegha, SA; Babatola, LJ; Dada, FA; Oyeleye, SI | 1 |
Aylı, M; Caliskan, E; Coban, SN; Esme, P; Ugur, B | 1 |
Brauers, K; Coonen, MLJ; Jennen, D; Kleinjans, JCS; Olde Damink, SWM; Schaap, FG; Van den Hof, WFPM; van Herwijnen, M | 1 |
Berti, E; Damiani, G; Fiore, M; Leone, S; Maraolo, AE | 1 |
Dawson, N; Kassab, L; Patel, A; Ton, A | 1 |
Caballero, D; Caballero-Velázquez, T; Castilla-Llorente, C; Encinas, C; Heras, I; López-Corral, L; Martino, R; Pérez-Simón, JA; Rosiñol, L; Sampol, A; San Miguel, J; Serrano, D | 1 |
Huang, H; Li, YQ; Liu, HM; Wu, XC; Xin, HW; Yu, AR; Zhang, L | 1 |
Brauers, K; Coonen, ML; Kleinjans, JC; Lommen, A; Van den Hof, WF; van Herwijnen, M; Van Summeren, A; Wodzig, WK | 1 |
Akbulut, S; Dogan, Z; Elbe, H; Eris, C; Otan, E; Toprak, G; Turkoz, Y; Yalcin, E | 1 |
Driessen, M; Kienhuis, AS; Pennings, JL; van der Ven, LT; Vitins, AP; Water, Bv | 1 |
Brauers, K; Coonen, ML; Gaj, S; Jennen, DG; Kleinjans, JC; Ruiz-Aracama, A; van Delft, JH; Van den Hof, WF; Van Summeren, A; Wodzig, WK | 1 |
Choi, YH; Jung, SH; Kim, HS; Kim, SG; Ko, MS; Lee, CH; Lee, JS | 1 |
Almeida, JM; Camargo, C; de Freitas, KM; Diamante, MA; Dolder, H; Jorge, MH; Monteiro, JC; Vale, JS | 1 |
Akool, el-S | 1 |
Chen, CJ; Cheng, TT; Lin, JC; Lin, KM | 1 |
Bašić-Jukić, N; Ivandić, E | 1 |
Funakami, Y; Kato, Y; Nagai, N; Tanino, T | 1 |
Aamdal, S; Andersson, Y; Brunsvig, P; Dueland, S; Engebraaten, O; Fodstad, Ø; Juell, S | 1 |
El-Sherbeeny, NA; Nader, MA | 1 |
Hu, J; Jaeschke, H; Lemasters, JJ; McGill, MR; Ramshesh, VK | 1 |
Akküçük, S; Karaboğa, I; Motor, S; Nacar, A; Nacar, E; Okuyan, HM; Ozkan, OV; Sefil, NK | 1 |
Diem, S; Larkin, J; Spain, L | 1 |
Annaert, P; Bachellier, P; Baze, A; Heyd, B; Oorts, M; Richert, L; Zacharias, T | 1 |
Cai, P; Li, J; Liu, F; Metushi, I; Nakayawa, T; Uetrecht, J; Vega, L | 1 |
Exton, LS; Kirby, B; Mohd Mustapa, MF; Smith, CH; Warren, RB; Weatherhead, SC; Yesudian, PD | 1 |
Almario, EE; Borlak, J; Chen, M; Suzuki, A | 1 |
Akimaru, K; Ishikawa, Y; Kakinuma, D; Kanada, T; Mamada, Y; Mizuguchi, Y; Tajiri, T; Taniai, N; Yoshida, H | 1 |
Pari, L; Sivasankari, R | 1 |
Catarsi, P; Ghiggeri, GM; Ginevri, F; Gusmano, R; Magnasco, A; Perfumo, F; Rossi, A | 1 |
Azarpira, N; Baghban, M; Jamshidzadeh, A; Mohammadi Bardbori, A; Niknahad, H | 1 |
Cederbaum, AI; Zhuge, J | 1 |
Allen, CE; Horton, T; Jones, JY; McClain, KL; Thompson, PA; Vinks, AA | 1 |
Atasever, A; Esrefoglu, M; Kurus, M; Sogutlu, G | 1 |
Andrade, RJ; Cotta, J; Lucena, MA; Robles, M; Toscano, E | 1 |
El-Dayem, WA; Eladl, M; Elgalaly, H; Kamel, M; Maarouf, AM; Radwan, M; Salem, EA; Salem, NA | 1 |
Bayrak, R; Delibasi, T; Ekiz, F; Erarslan, E; Koca, C; Turkcu, UO; Uz, B | 1 |
Bouwman, FG; Kleinjans, JC; Mariman, EC; Noben, JP; Renes, J; van Delft, JH; Van Summeren, A | 1 |
Chaudhuri, S; Hennings, L; Hinson, JA; James, LP; Letzig, L; McCullough, SS; Simpson, PM | 1 |
Jaeschke, H; McGill, MR; Ramachandran, A | 1 |
Couch, L; Fang, JL; Guo, L; Higuchi, M; Li, Y | 1 |
Burton, L; Chiuzan, C; Garrett-Mayer, E; Heath, TS; Hudspeth, MP; Nista, E; Ragucci, D | 1 |
Chen, XC; Xu, Q | 1 |
Ducloux, D | 1 |
De Carlis, LG; De Gasperi, A; Mancini, V; Marbello, L; Morra, E; Muti, G; Nosari, A | 1 |
Hagar, HH | 1 |
Arduino, JM; Chodakewitz, J; Hachem, R; Kartsonis, N; Lipka, CJ; Marr, KA; Ngai, AL; Papanicolaou, G; Sable, C; Somani, J | 1 |
Armstrong, JS; Cheung, NS; Halliwell, B; Rose, P; Siau, JL; Tan, GS; Whiteman, M | 1 |
Bianchi, R; Buffoli, B; Rezzani, R; Rodella, L; Stacchiotti, A | 1 |
Niemczyk, M; Paczek, L; Perkowska, A; Porowski, D; Wyzgał, J | 1 |
Fujiwara, M; Hori, A; Kami, M; Kanda, Y; Komatsu, T; Koyama, R; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Murashige, N; Seki, K; Tanaka, Y; Taniguchi, S; Wake, A; Yuji, K | 1 |
Durgut, R; Duru, M; Kaya, H; Koc, A; Sogut, S; Uz, E; Yilmaz, HR | 1 |
Aoyama, T; Arai, K; Ikejima, K; Kon, K; Lemasters, JJ; Okumura, K; Sato, N; Takei, Y | 1 |
Lai, FF; Ma, KF; Qi, LY | 1 |
Amudha, G; Josephine, A; Nithya, K; Preetha, SP; Varalakshmi, P; Veena, CK | 1 |
Behre, G; Christopeit, M; Eikam, M | 1 |
Anderle, SK; Geratz, JD; Pryzwansky, KB; Tidwell, RR | 1 |
Greenberg, E; Moore, RA; Tangen, L | 1 |
Caraceni, P; Cooper, DK; Deal, S; Fagiuoli, S; Gavaler, J; Jazzar, A; Sisson, S; Van Thiel, DH; Wright, HI; Zuhdi, N | 1 |
Wood, P; Yin, JA | 1 |
Holzer, H; Horina, JH; Kenner, L; Krejs, GJ; Wirnsberger, GH | 1 |
Kahan, BD; Lindholm, A | 1 |
Bouvier, R; Cochat, P; Dubourg-Derain, L; Philippe, N; Vial, T; Vinot, O | 1 |
Lemasters, JJ; Trost, LC | 1 |
Demetris, AJ; Felekouras, ES; Fung, JJ; Jain, AB; Lee, RG; Tsamandas, AC | 1 |
Brooks, RH; Pincus, T; Stein, CM | 1 |
Fritsche, H; Ippoliti, C; Khouri, I; Körbling, M; Przepiorka, D; Warkentin, D; Woo, M | 1 |
Crespo Valadés, E; González Fernández, MR; Jimeno Torres, B; Robles Pérez, NR | 1 |
Asakura, W; Hara, K; Kobayashi, T; Nakano, Y; Okamoto, T; Tsuzuike, N | 1 |
Kobayashi, T; Okamoto, T | 1 |
Hara, A; Hitomi, Y; Okamoto, T | 1 |
Cartner, S; Contreras, JL; Eckhoff, DE; Frenette, L; Neville, DM; Robbin, ML; Thomas, FT; Thomas, JM | 1 |
Agranat, O; Freimark, D; Gruberg, L; Har-Zahav, Y | 1 |
Sato, S; Suzuki, K; Takikawa, Y | 1 |
Cartier, VA; Chousterman, M; Gordin, J; Hagège, H; Lons, T; Ngo, MD; Rosa, I | 1 |
DeCicco, LA; Rikans, LE; Yamano, T | 1 |
Chicharro, Mf; Guarner, L; Malagelada, J; Planas, M; Vilaseca, J | 1 |
Busca, A; Lanino, E; Manfredini, L; Messina, C; Miniero, R; Nicolini, B; Rabusin, M; Saroglia, EM; Uderzo, C | 1 |
Kubota, T; Lynch, SV; Matsunami, H; Morioka, D; Nakatani, Y; Sekido, H; Shimada, H; Strong, RW; Takeda, K; Togo, S | 1 |
Enomoto, N; Ikejima, K; Kolinsky, M; Li, X; Raleigh, JA; Thurman, RG; von Frankenberg, M; Yamashina, S; Zhong, Z | 1 |
Jiang, XL; Li, WB; Quan, QZ; Sun, ZQ; Wang, D; Wang, YJ; Zhang, XL | 1 |
Berg, U; Ingelman-Sundberg, M; Lytton, SD; Nemeth, A | 1 |
Abu-Elmagd, K; Alessiani, M; Demetris, AJ; Fung, JJ; Jain, A; McCauley, J; Starzl, TE; Takaya, S; Todo, S; Van Thiel, DH | 1 |
Fung, J; Gavaler, JS; Starzl, TE; Van Thiel, DH; Wright, HI | 1 |
García, R; Henríquez La Roche, C; Herrera, J; Marín, C; Rodríguez-Iturbe, B; Rubio, L | 1 |
Adorno, D; Casciani, CU; Cervelli, V; Cesarini, A; Filingeri, V; Iacona, A; Orsini, D; Rossetti, A | 1 |
Baldwin, JC; Billingham, ME; Jamieson, SW; Ogunnaike, HO; Porter, KA; Starkey, TD | 1 |
9 review(s) available for cyclosporine and Chemical and Drug Induced Liver Injury
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug Induced Liver Injury (DILI). Mechanisms and Medicinal Chemistry Avoidance/Mitigation Strategies.
Topics: Animals; Cell Line; Cell Survival; Chemical and Drug Induced Liver Injury; Drug Discovery; Drug Evaluation, Preclinical; Hepatocytes; Humans; Liver; Mitochondria, Liver; Pharmaceutical Preparations; Risk Assessment; Tissue Distribution | 2020 |
Liver Illness and Psoriatic Patients.
Topics: Autoimmune Diseases; Chemical and Drug Induced Liver Injury; Cyclosporine; Humans; Inflammation; Liver; Liver Diseases; Methotrexate; Psoriasis | 2018 |
Management of toxicities of immune checkpoint inhibitors.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Antineoplastic Agents; Carcinoma, Renal Cell; Chemical and Drug Induced Liver Injury; Colitis; CTLA-4 Antigen; Cyclosporine; Diarrhea; Drug Eruptions; Humans; Immunosuppressive Agents; Infliximab; Ipilimumab; Kidney Neoplasms; Lung Neoplasms; Melanoma; Mycophenolic Acid; Neoplasms; Nivolumab; Pituitary Diseases; Programmed Cell Death 1 Receptor; Skin Neoplasms; Tacrolimus; Thyroiditis | 2016 |
Cyclosporin and organ specific toxicity: clinical aspects, pharmacogenetics and perspectives.
Topics: Brain; Chemical and Drug Induced Liver Injury; Cyclosporine; Humans; Immunosuppressive Agents; Kidney; Neurotoxicity Syndromes; Organ Specificity; Pharmacogenetics | 2008 |
Is cyclosporine withdrawal a therapeutic option in renal transplant recipients with chronic allograft dysfunction?
Topics: Calcineurin Inhibitors; Chemical and Drug Induced Liver Injury; Chronic Disease; Clinical Trials as Topic; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation | 2003 |
Oxymetholone hepatotoxicity enhanced by concomitant use of cyclosporin A in a bone marrow transplant patient.
Topics: Adolescent; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Synergism; Humans; Male; Oxymetholone | 1994 |
Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation.
Topics: Acute Kidney Injury; Adolescent; Adult; Chemical and Drug Induced Liver Injury; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Hyperglycemia; Hyperkalemia; Hypertension; Immunosuppressive Agents; Incidence; Infections; Male; Methylprednisolone; Middle Aged; Patient Compliance; Retrospective Studies; Seizures; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 1997 |
[Physiopathology and therapy of fulminant hepatitis].
Topics: Chemical and Drug Induced Liver Injury; Cyclosporine; Hemofiltration; Hepatic Encephalopathy; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Liver Failure; Plasma Exchange; T-Lymphocytes, Cytotoxic; Tumor Necrosis Factor-alpha | 1999 |
7 trial(s) available for cyclosporine and Chemical and Drug Induced Liver Injury
Article | Year |
---|---|
Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boronic Acids; Bortezomib; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclosporine; Drug Synergism; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Male; Melphalan; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Peripheral Nervous System Diseases; Protease Inhibitors; Pyrazines; Remission Induction; Reoperation; Salvage Therapy; T-Lymphocyte Subsets; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Vidarabine | 2013 |
Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin.
Topics: Adult; Aged; Alanine Transaminase; Animals; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Bone Marrow Neoplasms; Carcinoma; Cell Adhesion Molecules; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Interactions; Epithelial Cell Adhesion Molecule; Female; Half-Life; Humans; Immunoconjugates; Infusions, Intravenous; Lethal Dose 50; Macaca fascicularis; Male; Maximum Tolerated Dose; Mice; Mice, Inbred BALB C; Middle Aged; Neoplasm Micrometastasis; Neoplasms; Treatment Outcome | 2015 |
Incidence and etiology of hepatic dysfunction in heart transplant recipients receiving a cyclosporine-based triple immunosuppressive therapy.
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppression Therapy; Liver Diseases; Liver Function Tests; Time Factors | 1994 |
Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.
Topics: Adult; Aged; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Monitoring; Female; Follow-Up Studies; Graft Rejection; Humans; Kidney Diseases; Kidney Transplantation; Male; Metabolic Clearance Rate; Middle Aged; Racial Groups; Regression Analysis | 1993 |
Effect of combination therapy with cyclosporine and methotrexate on liver function test results in rheumatoid arthritis.
Topics: Alkaline Phosphatase; Antirheumatic Agents; Arthritis, Rheumatoid; Bilirubin; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Therapy, Combination; Humans; Liver; Liver Diseases; Liver Function Tests; Methotrexate | 1997 |
Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation.
Topics: Adolescent; Adrenal Cortex Hormones; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Drug Resistance; Female; Gastrointestinal Diseases; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Opportunistic Infections; Prodrugs; PUVA Therapy; Safety; Transplantation, Homologous; Treatment Outcome | 2000 |
Interferon therapy of hepatitis following liver transplantation under FK 506 or cyclosporine.
Topics: Chemical and Drug Induced Liver Injury; Cyclosporine; Humans; Interferon Type I; Liver Transplantation; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 1991 |
94 other study(ies) available for cyclosporine and Chemical and Drug Induced Liver Injury
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
The human hepatocyte TXG-MAPr: gene co-expression network modules to support mechanism-based risk assessment.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Datasets as Topic; Endoplasmic Reticulum Stress; Gene Expression Profiling; Gene Regulatory Networks; Hepatocytes; Humans; Oxidative Stress; Rats; Risk Assessment; Species Specificity; Toxicogenetics; Tunicamycin | 2021 |
Pyrvinium pamoate ameliorates cyclosporin A- induced hepatotoxicity via the modulation of Wnt/β-catenin signaling and upregulation of PPAR-γ.
Topics: Animals; beta Catenin; Chemical and Drug Induced Liver Injury; Cyclosporine; Immunosuppressive Agents; Interleukin-1beta; Liver; Male; Mice; NF-kappa B; PPAR gamma; Protective Agents; Pyrvinium Compounds; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53; Up-Regulation; Wnt Signaling Pathway | 2022 |
Cyclosporine A induces hepatotoxicity in zebrafish larvae via upregulating oxidative stress.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Larva; Oxidative Stress; Zebrafish | 2023 |
Niclosamide modulates cyclosporin A-induced hepatotoxicity in a mouse model: PPAR-γ and Wnt/β-catenin crosstalk.
Topics: Animals; beta Catenin; Chemical and Drug Induced Liver Injury; Cyclosporine; Male; Mice; Niclosamide; PPAR gamma; Wnt Signaling Pathway | 2023 |
[Aplastic anemia following drug-induced liver injury].
Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Chemical and Drug Induced Liver Injury; Cyclosporine; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male | 2019 |
The protective effect of resveratrol against cyclosporine A-induced oxidative stress and hepatotoxicity.
Topics: Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Cyclosporine; Lipid Peroxidation; Liver; Oxidative Stress; Rats; Resveratrol; Thiobarbituric Acid Reactive Substances | 2021 |
Topics: Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Drugs, Chinese Herbal; Ions; Kidney; Liver; NF-E2-Related Factor 2; Rats; Schisandra; Signal Transduction | 2021 |
High-Throughput Screening to Evaluate Inhibition of Bile Acid Transporters Using Human Hepatocytes Isolated From Chimeric Mice.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; Bile Acids and Salts; Bile Canaliculi; Chemical and Drug Induced Liver Injury; Cyclosporine; Gene Expression; Hepatocytes; High-Throughput Screening Assays; Humans; Mice; Mice, Transgenic | 2020 |
Metformin and silymarin afford protection in cyclosporine A induced hepatorenal toxicity in rat by modulating redox status and inflammation.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Inflammation; Kidney Diseases; Male; Metformin; Oxidation-Reduction; Rats; Rats, Wistar; Silymarin | 2021 |
The combination of N-acetylcysteine and cyclosporin A reduces acetaminophen-induced hepatotoxicity in mice.
Topics: Acetaminophen; Acetylcysteine; Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Liver; Mice | 2021 |
Hepatoprotective effect of the tyrosine kinase inhibitor nilotinib against cyclosporine-A induced liver injury in rats through blocking the Bax/Cytochrome C/caspase-3 apoptotic signaling pathway.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Chemical and Drug Induced Liver Injury; Cyclosporine; Cytochromes c; Male; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Signal Transduction | 2021 |
Evaluation of different almond (
Topics: Acetylcholinesterase; Animals; Antioxidants; Brain; Chemical and Drug Induced Liver Injury; Cyclosporine; Lipid Peroxidation; Liver; Male; Oxidative Stress; Plant Extracts; Prunus dulcis; Rats; Rats, Wistar; Terminalia | 2021 |
A case of psoriasis successfully treated by extracorporeal photopheresis during COVID-19 pandemic.
Topics: Acitretin; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Contraindications, Drug; COVID-19; Cyclosporine; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Nails; Pandemics; Photopheresis; Psoriasis; Quality of Life; SARS-CoV-2; Severity of Illness Index; Ultraviolet Therapy | 2021 |
Validation of gene expression profiles from cholestatic hepatotoxicants in vitro against human in vivo cholestasis.
Topics: Animals; Bile Acids and Salts; Cells, Cultured; Chemical and Drug Induced Liver Injury; Chlorpromazine; Cholestasis; Cyclosporine; Ethinyl Estradiol; Hep G2 Cells; Hepatocytes; Humans; Liver; Mice; Transcriptome | 2017 |
Severe acute hepatitis in drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome resolved following cyclosporine.
Topics: Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Hypersensitivity Syndrome; Eosinophilia; Hepatitis; Humans | 2020 |
Association of CYP3A4*18B and CYP3A5*3 polymorphism with cyclosporine-related liver injury in Chinese renal transplant recipients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asian People; Chemical and Drug Induced Liver Injury; Chi-Square Distribution; China; Cyclosporine; Cytochrome P-450 CYP3A; Drug Therapy, Combination; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Logistic Models; Male; Middle Aged; Odds Ratio; Phenotype; Risk Factors; Time Factors; Young Adult | 2014 |
Integrative cross-omics analysis in primary mouse hepatocytes unravels mechanisms of cyclosporin A-induced hepatotoxicity.
Topics: Animals; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cyclosporine; Gene Expression Profiling; Gene Expression Regulation; Genetic Markers; Genomics; Hepatocytes; Immunosuppressive Agents; Liver; Male; Metabolomics; Mice; Mice, Inbred C57BL; MicroRNAs; Primary Cell Culture; Protein Interaction Mapping; Protein Interaction Maps; Proteomics; Risk Assessment; RNA, Messenger; Systems Biology | 2014 |
Effects of antioxidant agents against cyclosporine-induced hepatotoxicity.
Topics: Alanine Transaminase; Alkaline Phosphatase; Allopurinol; Animals; Antioxidants; Aspartate Aminotransferases; Bilirubin; Body Weight; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Evaluation, Preclinical; Liver; Male; Melatonin; Random Allocation; Rats, Sprague-Dawley; Ursodeoxycholic Acid; Xanthine Oxidase | 2015 |
A transcriptomics-based hepatotoxicity comparison between the zebrafish embryo and established human and rodent in vitro and in vivo models using cyclosporine A, amiodarone and acetaminophen.
Topics: Acetaminophen; Amiodarone; Analgesics, Non-Narcotic; Animals; Anti-Arrhythmia Agents; Chemical and Drug Induced Liver Injury; Cyclosporine; Embryo, Nonmammalian; Gene Expression; Hepatocytes; Humans; Immunosuppressive Agents; In Vitro Techniques; Mice; Mice, Inbred C57BL; Rats; Transcriptome; Zebrafish | 2015 |
Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro.
Topics: Chemical and Drug Induced Liver Injury; Cyclosporine; Dose-Response Relationship, Drug; Gene Expression Profiling; Hep G2 Cells; Humans; Immunosuppressive Agents; In Vitro Techniques; Metabolomics; MicroRNAs; RNA, Messenger; Transcriptome | 2015 |
Tacrolimus therapy causes hepatotoxicity in patients with a history of liver disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Bilirubin; Biomarkers; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Monitoring; Electronic Health Records; Female; Humans; Immunosuppressive Agents; Liver Diseases; Male; Middle Aged; Republic of Korea; Retrospective Studies; Risk Factors; Tacrolimus; Time Factors; Young Adult | 2015 |
The effects of cyclosporin A and Heteropterys tomentosa on the rat liver.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Immunosuppressive Agents; Liver; Male; Malpighiaceae; Plant Extracts; Rats; Rats, Wistar; Time Factors | 2015 |
Molecular mechanisms of the protective role of wheat germ oil against cyclosporin A-induced hepatotoxicity in rats.
Topics: Animals; Antioxidants; Biomarkers; Chemical and Drug Induced Liver Injury; Cyclosporine; Cytoprotection; Disease Models, Animal; Enzyme Inhibitors; Interleukin-2; Lipid Peroxidation; Liver; Male; NF-kappa B; Nitric Oxide Synthase Type II; Oxidative Stress; Phytotherapy; Plant Oils; Plants, Medicinal; Rats, Wistar; Reactive Oxygen Species; Triticum | 2015 |
Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study.
Topics: Adalimumab; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chemical and Drug Induced Liver Injury; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Hepatitis C, Chronic; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
[Liver damage caused by atorvastatin and cyclosporine in patients with renal transplant].
Topics: Atorvastatin; Chemical and Drug Induced Liver Injury; Cyclosporine; Graft Rejection; Graft Survival; Heptanoic Acids; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Liver; Male; Middle Aged; Pyrroles | 2014 |
Cyclosporin A-sensitive cytotoxicity of flurbiprofen non-stereoselectively mediated by cytochrome P450 metabolism in three-dimensional cultured rat hepatocytes.
Topics: Adenosine Triphosphate; Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Cytochrome P-450 Enzyme System; Flurbiprofen; Hepatocytes; Ibuprofen; L-Lactate Dehydrogenase; Male; Mitochondria; Naproxen; Phenylpropionates; Rats; Rats, Wistar; Stereoisomerism | 2015 |
The protective effect of vildagliptin in chronic experimental cyclosporine A-induced hepatotoxicity.
Topics: Adamantane; Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Catalase; Chemical and Drug Induced Liver Injury; Cyclosporine; Glutathione; Glutathione Peroxidase; Lipid Peroxidation; Liver; Male; Nitriles; Oxidative Stress; Protective Agents; Pyrrolidines; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vildagliptin | 2016 |
Low Dose Acetaminophen Induces Reversible Mitochondrial Dysfunction Associated with Transient c-Jun N-Terminal Kinase Activation in Mouse Liver.
Topics: Acetaminophen; Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Dose-Response Relationship, Drug; Injections, Intraperitoneal; JNK Mitogen-Activated Protein Kinases; Liver; Male; Mice, Inbred C57BL; Microscopy, Fluorescence, Multiphoton; Mitochondria, Liver | 2016 |
Investigation of the protective effect of erdosteine against cyclosporine-induced injury in rat liver with histological and biochemical methods.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cyclosporine; Expectorants; Glutathione Peroxidase; Immunosuppressive Agents; Liver; Male; Malondialdehyde; Microscopy; Random Allocation; Rats, Wistar; Superoxide Dismutase; Thioglycolates; Thiophenes | 2015 |
Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes.
Topics: Bile Acids and Salts; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cholestasis; Cyclosporine; Hepatocytes; Humans; Risk Assessment; Urea | 2016 |
Exploring an animal model of amodiaquine-induced liver injury in rats and mice.
Topics: Agranulocytosis; Amodiaquine; Animals; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cyclosporine; Cytokines; Disease Models, Animal; Humans; Killer Cells, Natural; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Inbred BN; Remission, Spontaneous; Spinocerebellar Degenerations; T-Lymphocytes, Regulatory; Th17 Cells; Tretinoin | 2016 |
British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016.
Topics: Adult; Alcohol Drinking; Biological Products; Bone Marrow Diseases; Checklist; Chemical and Drug Induced Liver Injury; Chickenpox; Child; Counseling; Cyclosporine; Dermatologic Agents; Drug Administration Routes; Drug Administration Schedule; Drug Approval; Drug Interactions; Drug Monitoring; Drug Overdose; Evidence-Based Medicine; Female; Hepatitis, Viral, Human; HIV Infections; Humans; Intraoperative Complications; Kidney Diseases; Lung Diseases; Methotrexate; Nausea; Neoplasms; Off-Label Use; Patient Education as Topic; Patient Safety; Pregnancy; Pregnancy Complications; Retinoids; Skin Diseases; Tuberculosis; Ultraviolet Rays; Vaccination | 2016 |
Drug-Induced Liver Injury.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Disease Models, Animal; Humans; Medicine, Chinese Traditional; Valproic Acid; Zebrafish | 2017 |
Hepatotoxicity caused by both tacrolimus and cyclosporine after living donor liver transplantation.
Topics: Chemical and Drug Induced Liver Injury; Cyclosporine; Humans; Immunosuppressive Agents; Jaundice, Obstructive; Liver Transplantation; Living Donors; Male; Middle Aged; Tacrolimus | 2008 |
Effect of ellagic acid on cyclosporine A-induced oxidative damage in the liver of rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antioxidants; Aspartate Aminotransferases; Catalase; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Antagonism; Ellagic Acid; Glutathione Transferase; Immunosuppressive Agents; L-Lactate Dehydrogenase; Lipid Peroxidation; Liver; Liver Diseases; Male; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2008 |
Effects of tomato extract on oxidative stress induced toxicity in different organs of rats.
Topics: Acetaminophen; Amiodarone; Analgesics, Non-Narcotic; Animals; Anti-Arrhythmia Agents; Chemical and Drug Induced Liver Injury; Cyclosporine; Glutathione; Immunosuppressive Agents; Kidney Diseases; Lipid Peroxidation; Lung Diseases; Male; Oxidative Stress; Plant Extracts; Rats; Rats, Sprague-Dawley; Solanum lycopersicum | 2008 |
Inhibition of the mitochondrial permeability transition by cyclosporin A prevents pyrazole plus lipopolysaccharide-induced liver injury in mice.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cyclosporine; Lipid Peroxidation; Lipopolysaccharides; Liver; Liver Diseases; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitogen-Activated Protein Kinase 9; Necrosis; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Pyrazoles; Signal Transduction | 2009 |
Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosis.
Topics: Adolescent; Central Nervous System Diseases; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclosporine; Female; Humans; Infant; Liver Diseases; Lymphohistiocytosis, Hemophagocytic; Magnetic Resonance Imaging; Male; Models, Biological | 2009 |
Melatonin prevents cyclosporine-induced hepatotoxicity in rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Disease Models, Animal; Free Radical Scavengers; Immunosuppressive Agents; Male; Melatonin; Rats | 2009 |
[Hepatotoxicity induced by new immunosuppressants].
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Tumor Necrosis Factor-alpha | 2010 |
Protective effect of trapidil and l-arginine against renal and hepatic toxicity induced by cyclosporine in rats.
Topics: Animals; Arginine; Chemical and Drug Induced Liver Injury; Cyclosporine; Immunosuppressive Agents; Kidney Diseases; Male; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Trapidil; Vasodilator Agents | 2010 |
Effects of erdosteine on cyclosporine-A-induced hepatotoxicity in rats.
Topics: Animals; Antioxidants; Catalase; Chemical and Drug Induced Liver Injury; Cyclosporine; Glutathione Peroxidase; Immunosuppressive Agents; Liver; Liver Function Tests; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Thioglycolates; Thiophenes | 2011 |
Proteomics investigations of drug-induced hepatotoxicity in HepG2 cells.
Topics: Acetaminophen; Amiodarone; Blotting, Western; Cell Survival; Chemical and Drug Induced Liver Injury; Cluster Analysis; Cyclosporine; Drug-Related Side Effects and Adverse Reactions; Electrophoresis, Gel, Two-Dimensional; Hep G2 Cells; Humans; Pharmaceutical Preparations; Protein Biosynthesis; Protein Processing, Post-Translational; Proteins; Proteomics; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tandem Mass Spectrometry | 2011 |
Acetaminophen hepatotoxicity and HIF-1α induction in acetaminophen toxicity in mice occurs without hypoxia.
Topics: Acetaminophen; Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Dose-Response Relationship, Drug; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Immunosuppressive Agents; Male; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Nitroimidazoles; Oxidative Stress; Statistics, Nonparametric | 2011 |
Pathophysiological relevance of proteomics investigations of drug-induced hepatotoxicity in HepG2 cells.
Topics: Acetaminophen; Amiodarone; Chemical and Drug Induced Liver Injury; Cyclosporine; Gene Expression Regulation; Hep G2 Cells; Hepatocytes; Humans; Proteomics | 2011 |
Mitochondrial dysfunction induced by sertraline, an antidepressant agent.
Topics: Adenosine Triphosphate; Animals; Antidepressive Agents; Bongkrekic Acid; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cyclosporine; Dose-Response Relationship, Drug; Electron Transport Chain Complex Proteins; Energy Metabolism; Hepatocytes; L-Lactate Dehydrogenase; Male; Mitochondria, Liver; Mitochondrial ADP, ATP Translocases; Mitochondrial Diseases; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxidative Phosphorylation; Rats; Rats, Sprague-Dawley; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors | 2012 |
Folinic acid administration after MTX GVHD prophylaxis in pediatric allo-SCT.
Topics: Adolescent; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Female; Folic Acid Antagonists; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Leucovorin; Male; Methotrexate; Mucositis; Retrospective Studies; Severity of Illness Index; Stem Cell Transplantation; Survival Analysis; Transplantation, Homologous; Vitamin B Complex | 2013 |
CD4 T lymphocytes cause hepatocyte apoptosis by releasing Th1 cytokines in cellular immunological liver injury.
Topics: Animals; Apoptosis; CD4-Positive T-Lymphocytes; Chemical and Drug Induced Liver Injury; Cyclosporine; Ear Diseases; Edema; Female; Hepatocytes; Immunity, Cellular; Immunosuppressive Agents; Interleukin-2; Liver Diseases; Mice; Mice, Inbred BALB C; Picryl Chloride; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2002 |
Bone marrow hypoplasia complicating tacrolimus (FK506) therapy.
Topics: Adolescent; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Cyclosporine; Female; Humans; Immunosuppressive Agents; Liver Transplantation; N-Methyl-3,4-methylenedioxyamphetamine; Tacrolimus | 2004 |
The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats.
Topics: Administration, Oral; Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Antagonism; Immunosuppressive Agents; Injections, Subcutaneous; Liver; Male; Oxidative Stress; Rats; Rats, Wistar; Taurine; Thiobarbituric Acid Reactive Substances; Water Supply | 2004 |
Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Caspofungin; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunosuppressive Agents; Lipopeptides; Male; Middle Aged; Peptides, Cyclic; Retrospective Studies | 2004 |
Hypochlorous acid-mediated mitochondrial dysfunction and apoptosis in human hepatoma HepG2 and human fetal liver cells: role of mitochondrial permeability transition.
Topics: Animals; Apoptosis; Bongkrekic Acid; Carcinoma, Hepatocellular; Caspase 3; Caspase 7; Caspases; Cell Line; Cell Line, Tumor; Cell Survival; Chemical and Drug Induced Liver Injury; Cyclosporine; Cytochromes c; Humans; Hypochlorous Acid; Liver; Membrane Potentials; Mitochondria, Liver; Mitochondrial Swelling; Permeability; Rats | 2005 |
Protective role of melatonin in cyclosporine A-induced oxidative stress in rat liver.
Topics: Animals; Antioxidants; Chaperonin 60; Chemical and Drug Induced Liver Injury; Cyclosporine; Glutathione; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; HSP72 Heat-Shock Proteins; Immunosuppressive Agents; Liver; Liver Diseases; Male; Malondialdehyde; Melatonin; Membrane Proteins; Metallothionein; Oxidative Stress; Rats; Rats, Wistar | 2005 |
Sirolimus-associated hepatotoxicity in the kidney graft recipient.
Topics: Acute Disease; Adult; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Sirolimus; Steroids | 2005 |
Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Busulfan; Chemical and Drug Induced Liver Injury; Cholangitis; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Hematologic Diseases; Hematologic Neoplasms; Hepatic Veno-Occlusive Disease; Humans; Hyperbilirubinemia; Immunosuppressive Agents; Incidence; Infant, Newborn; Liver Diseases; Liver Function Tests; Male; Melphalan; Middle Aged; Postoperative Complications; Risk Factors; Tacrolimus; Tissue Donors; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2006 |
The protective effect of N-acetylcysteine against cyclosporine A-induced hepatotoxicity in rats.
Topics: Acetylcysteine; Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cyclosporine; Glutathione Peroxidase; Liver; Liver Diseases; Male; Malondialdehyde; Nitric Oxide; Rats; Rats, Wistar; Superoxide Dismutase | 2008 |
Role of apoptosis in acetaminophen hepatotoxicity.
Topics: Acetaminophen; Animals; Apoptosis; Cell Membrane Permeability; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cyclosporine; Glutathione; Mice; Microscopy, Confocal; Mitochondria, Liver; Necrosis; Oxidative Stress | 2007 |
[Gene expressions of LTC4 synthase homologs in Con A-induced mouse hepatitis and regulative effect of cyclosporine A].
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Concanavalin A; Cyclosporine; Gene Expression Regulation, Enzymologic; Glutathione Transferase; Hepatitis, Animal; Immunosuppressive Agents; Injections, Intravenous; Isoenzymes; Male; Mice; Mice, Inbred BALB C; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Role of sulphated polysaccharides from Sargassum Wightii in Cyclosporine A-induced oxidative liver injury in rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Immunosuppressive Agents; Liver; Male; Oxidative Stress; Polysaccharides; Rats; Rats, Wistar; Sargassum; Sulfates | 2008 |
Comedication of caspofungin acetate and cyclosporine A after allogeneic haematopoietic stem cell transplantation leads to negligible hepatotoxicity.
Topics: Antifungal Agents; Caspofungin; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Therapy, Combination; Echinocandins; Female; Germany; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lipopeptides; Male; Mycoses; Postoperative Complications; Retrospective Studies; Treatment Outcome | 2008 |
Control of glucan-induced systemic granulomatosis by cyclosporine A.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chemotaxis; Cyclosporine; Female; Glucans; Granuloma, Foreign-Body; Liver Diseases; Lung Diseases; Macrophages; Rats; Rats, Inbred Lew; Splenic Diseases | 1995 |
Cyclosporine-induced worsening of hepatic dysfunction in a patient with Crohn's disease and enterocutaneous fistula.
Topics: Adult; Bilirubin; Chemical and Drug Induced Liver Injury; Crohn Disease; Cutaneous Fistula; Cyclosporine; Humans; Intestinal Fistula; Liver Diseases; Male | 1995 |
Increased susceptibility for CsA-induced hepatotoxicity in kidney graft recipients with chronic viral hepatitis C.
Topics: Chemical and Drug Induced Liver Injury; Chronic Disease; Cyclosporine; Disease Susceptibility; Hepatitis C; Humans; Kidney Transplantation; Liver Function Tests; Retrospective Studies | 1993 |
Jaundice associated with concomitant use of norethandrolone and cyclosporine.
Topics: Adolescent; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Therapy, Combination; Female; Humans; Jaundice; Norethandrolone | 1993 |
The mitochondrial permeability transition: a new pathophysiological mechanism for Reye's syndrome and toxic liver injury.
Topics: Animals; Aspirin; Carboxylic Acids; Chemical and Drug Induced Liver Injury; Cyclosporine; Male; Membrane Potentials; Mitochondria, Liver; Mitochondrial Swelling; Rats; Rats, Sprague-Dawley; Reye Syndrome; Ruthenium Red; Structure-Activity Relationship; Valproic Acid | 1996 |
Central venulitis in the allograft liver: a clinicopathologic study.
Topics: Adult; Chemical and Drug Induced Liver Injury; Cyclosporine; Female; Graft Rejection; Hepatic Veins; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome; Vasculitis; Venules | 1997 |
[Acute nephrotoxicity resolved by cyclosporine A, induced by simultaneous administration of colchicine].
Topics: Acute Disease; Chemical and Drug Induced Liver Injury; Colchicine; Cyclosporine; Gout Suppressants; Humans; Immunosuppressive Agents; Male; Middle Aged | 1998 |
Expression of cytokine mRNA in extrahepatic organs in a mouse concanavalin A-hepatitis model.
Topics: Animals; CD4 Antigens; CD8 Antigens; Chemical and Drug Induced Liver Injury; Concanavalin A; Cyclosporine; Cytokines; Disease Models, Animal; Female; Liver; Lung; Mice; Mice, Inbred BALB C; RNA, Messenger; Spleen | 1998 |
Effects of immunosuppressants on concanavalin A-induced interleukin-2 mRNA expression in mouse liver.
Topics: Animals; Chemical and Drug Induced Liver Injury; Concanavalin A; Cyclosporine; Dexamethasone; Female; Gene Expression Regulation; Immunosuppressive Agents; Interleukin-2; Liver; Mice; Mice, Inbred BALB C; RNA, Messenger | 1998 |
The protective effect of cyclosporine A on anti-Fas antibody-induced hepatitis in mice.
Topics: Alanine Transaminase; Animals; Antibodies, Monoclonal; Caspase 3; Caspases; Chemical and Drug Induced Liver Injury; Cyclosporine; Cytokines; Dose-Response Relationship, Drug; fas Receptor; Female; Gene Expression Regulation; Immunosuppressive Agents; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C; RNA, Messenger | 1999 |
Tolerability and side effects of anti-CD3-immunotoxin in preclinical testing in kidney and pancreatic islet transplant recipients.
Topics: Animals; Capillary Leak Syndrome; CD3 Complex; Chemical and Drug Induced Liver Injury; Cyclosporine; Immune Tolerance; Immunotoxins; Islets of Langerhans Transplantation; Kidney Function Tests; Kidney Transplantation; Liver Function Tests; Macaca mulatta; Male; Methylprednisolone; Transplantation Conditioning | 1999 |
Acute myopathy induced by colchicine in a cyclosporine treated heart transplant recipient: possible role of the multidrug resistance transporter.
Topics: Acute Disease; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chemical and Drug Induced Liver Injury; Colchicine; Cyclosporine; Drug Resistance, Multiple; Drug Therapy, Combination; Gastrointestinal Diseases; Gout Suppressants; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Muscular Diseases; Syndrome | 1999 |
[Acute hepatitis in the course of cyclosporine therapy of Crohn's disease].
Topics: Adult; Chemical and Drug Induced Liver Injury; Crohn Disease; Cyclosporine; Female; Humans; Treatment Outcome | 1999 |
Attenuation of cadmium-induced liver injury in senescent male fischer 344 rats: role of Kupffer cells and inflammatory cytokines.
Topics: Age Factors; Alanine Transaminase; Animals; Cadmium; Carbon; Chemical and Drug Induced Liver Injury; Chemotaxis; Cyclosporine; Cytokines; Dose-Response Relationship, Drug; Drug Interactions; Gadolinium; Inflammation Mediators; Interleukin-1; Kupffer Cells; L-Iditol 2-Dehydrogenase; Male; Neutrophil Infiltration; Phagocytosis; Rats; Rats, Inbred F344; Time Factors | 2000 |
Does cyclosporin A worsen liver function in patients with inflammatory bowel disease and total parenteral nutrition?
Topics: Adult; Chemical and Drug Induced Liver Injury; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Liver Diseases; Liver Function Tests; Male; Parenteral Nutrition, Total; Retrospective Studies | 2000 |
Successful conversion from cyclosporine to tacrolimus for immunosuppression.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Biopsy, Needle; Chemical and Drug Induced Liver Injury; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Immunosuppressive Agents; Inflammation; Insulin; Liver Function Tests; Liver Transplantation; Male; Neutrophils; Tacrolimus | 2000 |
Cyclosporin A causes a hypermetabolic state and hypoxia in the liver: prevention by dietary glycine.
Topics: Animals; Body Weight; Calcium; Chemical and Drug Induced Liver Injury; Cyclosporine; Dietary Supplements; Dinoprostone; Eating; Glycine; Hypoxia; Immunosuppressive Agents; Kupffer Cells; Liver Diseases; Male; Mitochondria, Liver; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Urea | 2001 |
Protective effects of cyclosporine A on T-cell dependent ConA-induced liver injury in Kunming mice.
Topics: Animals; Chemical and Drug Induced Liver Injury; Concanavalin A; Cyclosporine; Disease Models, Animal; Immunosuppressive Agents; Liver; Liver Diseases; Male; Mice; Mice, Inbred Strains; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2001 |
Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs.
Topics: Adolescent; Adult; Antibody Specificity; Aryl Hydrocarbon Hydroxylases; Autoantibodies; Autoantigens; Azathioprine; Blotting, Western; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclosporine; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Epitopes; Female; Graft Rejection; Humans; Immunoglobulin G; Immunosuppressive Agents; Infant; Isoenzymes; Kidney Diseases; Kidney Transplantation; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Mixed Function Oxygenases; Postoperative Complications; Prednisone; Recombinant Fusion Proteins; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Tacrolimus | 2002 |
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients.
Topics: Adolescent; Adult; Aged; Biopsy; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Graft Rejection; Hepatic Artery; Hepatitis; Humans; Immunity, Cellular; Infant; Liver; Liver Diseases; Liver Transplantation; Male; Middle Aged; Tacrolimus | 1992 |
[Usefulness of ketoconazole combined with cyclosporin in renal transplantation].
Topics: Adolescent; Adult; Azathioprine; Biotransformation; Chemical and Drug Induced Liver Injury; Cyclosporine; Cytochrome P-450 Enzyme Inhibitors; Drug Therapy, Combination; Female; Humans; Immunosuppression Therapy; Ketoconazole; Kidney Diseases; Kidney Transplantation; Liver Function Tests; Male; Middle Aged; Prednisone | 1991 |
Reduced nephrotoxicity and hepatoxicity in cyclosporin A therapy by enalapril and spironolactone in rats.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Therapy, Combination; Enalapril; Kidney Diseases; Liver Diseases; Male; Rats; Rats, Sprague-Dawley; Spironolactone | 1991 |
An assessment of Nva2-cyclosporine in primate cardiac transplantation.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cyclosporine; Cyclosporins; Heart Transplantation; Immunosuppression Therapy; Kidney Diseases; Macaca fascicularis; Myocardium; Time Factors | 1987 |